Clinical Trials in California

Showing 5361-5380 of 8,631 trials

A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes

NCT03433677

The purpose of this study is to evaluate the compatibility and safety of LY900014 and insulin lispro with an external continuous subcutaneous insulin infusion system in adult participants with type 1 diabetes.

Diabetes Type 1

Eli Lilly and Company49 participantsStarted Feb 2018

Fresno, California, United States • Aurora, Colorado, United States • Atlanta, Georgia, United States +2 more locations

COMPLETED62 miles

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

NCT00690469

This laboratory study is looking at genetic mutations and environmental exposure in young patients with retinoblastoma and in their parents and young healthy unrelated volunteers. Gathering information about gene mutations and environmental exposure may help doctors learn more about the causes of retinoblastoma in young patients.

Extraocular RetinoblastomaIntraocular RetinoblastomaRecurrent Retinoblastoma

Children's Oncology Group234 participantsStarted Jun 2008

Los Angeles, California, United States • Madera, California, United States • San Francisco, California, United States +49 more locations

A Study of LY900014 and Insulin Lispro With an External Continuous Subcutaneous Insulin Infusion System in Adult Participants With Type 1 Diabetes

Genetic Mutations and Environmental Exposure in Young Patients With Retinoblastoma and in Their Parents and Young Healthy Unrelated Volunteers

Find Trials by Condition in California

A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

A Study of Tabalumab (LY2127399) in Participants With Previously Treated Multiple Myeloma (MM)

A Study of Lampalizumab Intravitreal Injections Administered Every Two Weeks or Every Four Weeks to Participants With Geographic Atrophy

An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation

A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease

Continued Safety Monitoring of Solanezumab (LY2062430) in Alzheimer's Disease

VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer

A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

A Randomized Phase 2 Study of Atezolizumab (an Engineered Anti-PDL1 Antibody) Compared With Docetaxel in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Failed Platinum Therapy - "POPLAR"

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

Building an Optimal Hand Hygiene Bundle

Optimizing Management of the 2nd Stage of Labor: Multicenter Randomized Trial

A Study in Advanced Solid Tumors

Evaluating Progression of and Diagnostic Tools for Primary Ciliary Dyskinesia in Children and Adolescents

Brain Tissue Oxygen Monitoring in Traumatic Brain Injury (TBI)

Study of Ramucirumab in Ovarian Cancer